Tag: Lexaria Bioscience Corp (NASDAQ: LEXX)


DehydraTECH from Lexaria Bioscience Corp (NASDAQ: LEXX) Has Significantly Enhanced the Delivery of Colchicine in its VIRAL-A20-3 Study

Lexaria Bioscience Corp (NASDAQ: LEXX)┬áis a worldwide innovator for drug delivery platforms. The company recently announced that its pharmacokinetics and tolerability VIRAL-A20-3 study is done, and it achieved positive results. The study showed how DehydraTECH was able to enable colchicine, one of the many drugs Lexaria has tested with SARS-CoV-2, […]